Site Maintenance will take place from 4:00 PM on 2024-04-29 to 9:00 AM on 2024-05-01.
Please do not make any content change during this time, otherwise all the changes will be lost.

Researcher

Dr Ben Kong

Keywords

Fields of Research (FoR)

Oncology and carcinogenesis, Tumour immunology

Biography

Dr Ben Kong is a Senior Research Fellow in Poor Outcomes Cancers within SPHERE Cancer Clinical Academic Group. He is appointed as a Medical Oncologist at Prince of Wales Hospital where he treats patients with lung and head and neck cancers. He is also a Research Fellow at the NHMRC Clinical Trials Centre where he is responsible for the design and conduct of investigator-initiated cancer clinical trials with the Co-operative Group for...view more

Dr Ben Kong is a Senior Research Fellow in Poor Outcomes Cancers within SPHERE Cancer Clinical Academic Group. He is appointed as a Medical Oncologist at Prince of Wales Hospital where he treats patients with lung and head and neck cancers. He is also a Research Fellow at the NHMRC Clinical Trials Centre where he is responsible for the design and conduct of investigator-initiated cancer clinical trials with the Co-operative Group for Neuro-Oncology (COGNO). 

Prior to joining SPHERE, he completed his PhD in Cancer Immunology within the Dendritic Cell Research Group at the ANZAC Research Institute with Professor Derek Hart, characterising circulating dendritic cells in patients with glioblastoma and developing pre-clinical studies examining combination immune checkpoint inhibitors with dendritic cell vaccination using CMV as a model tumour antigen. He is currently leading clinical research in lung cancer and brain metastases with the aim of extending this into translational research in cancers affecting the central nervous system to develop more effective treatments in brain cancer. 

Ben is a member of the UNSW Australian Centre for NanoMedicine

 

 


My Grants

2022/MRF2023943 - Supporting Australian Brain Cancer Research with an integrated network of platforms (Associate Investigator)

2021/MRF2015365 - LUMOS: Low and Anaplastic Grade Glioma Umbrella Study of Molecular Guided TherapieS (Associate Investigator)

 

 


My Qualifications

BSc (Hons I), MBBS (USyd), Grad Cert Drug Development (UNSW), PhD (Usyd), FRACP


My Research Activities

Predictive factor in treatment sequencing for lung cancer brain metastases treated with immunotherapy

Radiomic biomarkers of response in brain metastases

Biomarkers of response to immunotherapy and precision medicine based approaches to lung cancer

Development of brain cancer clinical trials and translational research

View less

Location

Level 4, Lowy Cancer Research Centre

Contact

+61 2 9382 5111